Professor of Medicine 医学教授

Malignant Hematology, Stem Cell Transplantation and Cellular Therapy Section

Vanderbilt University Medical Center, Nashville, TN

田纳西州纳什维尔范德比尔特大学医学中心，恶性血液学、干细胞移植和细胞治疗科

Other Experience and Professional Memberships  学术任职

He is Co-Editor-in-Chief of journals Bone Marrow Transplantation (EBMT journal) and Clinical Hematology International (IACH journal) and associate editor of British Journal of Haematology (BSH), Transplantation and Cellular Therapy (ASTCT journal, formerly BBMT); and also serves as an editorial advisory board member for several journals in the field. Dr Savani is currently leader of the Conditioning Regimen Subcommittee of the Acute Leukemia Working Party of the EBMT. He also serves as Co-Chair Regimen-Related Toxicity and Supportive Care-CIBMTR and medical monitor for Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). Dr Savani is a member of the ASH Committee on Practice (COP). He has recently edited several special issues for Seminars in Hematology, Hematology/ Oncology Clinics of North America and edited Wiley books entitled "Blood and Marrow Transplantation Long Term Management: Prevention and Complications" (first ed 2014, second ed May 2021) and "Clinical guide to transplantation in lymphomas" (first ed 2015). Co-authored handbook on Leukemia (FAST FACTS: Leukemia, first ed 2019).

他是 Bone Marrow Transplantation（EBMT杂志）和 Clinical Hematology International（IACH杂志）的联合主编，也是 British Journal of Haematology（BSH）、Transplantation and Cellular Therapy（ASTCT杂志，前称BBMT）的副主编；同时，他还是该领域多个杂志的编辑顾问委员会成员。Savani博士目前是EBMT急性白血病移植预处理方案小组的领导人。他还担任CIBMTR（国际血液和骨髓移植研究中心）的预处理相关毒性和支持性护理委员会的联合主席，以及血液和骨髓移植临床试验网络（BMT-CTN）的医学监督。Savani博士是ASH实践委员会（COP）的成员。他最近为 Seminars in Hematology 和 Hematology/Oncology Clinics of North America 杂志编辑了数个特刊，并编辑了Wiley出版社的书籍 Blood and Marrow Transplantation Long Term Management: Prevention and Complications（第一版2014年，第二版2021年5月）和 Clinical guide to transplantation in lymphomas（第一版2015年）。他还共同编写了 handbook on Leukemia（FAST FACTS: Leukemia，第一版2019年）。